As of 10:31 AM on the 4th, Celltrion Pharm is trading at 128,400 KRW, up 4.39% from the previous day. This represents a 78.33% increase compared to May 7. Celltrion Pharm is known as a company specializing in pharmaceuticals and health supplements.
Today, foreigners are tentatively recorded as net sellers of 17,000 shares. Over the past 5 days, individual investors have net sold 756,756 shares, while foreigners and institutions have net bought 753,074 shares and 5,892 shares, respectively.
On June 3, Celltrion Pharm became an issue in the market with news titled "Insulin injection development and consecutive days of COVID-19 treatment experiment results..."
[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and financial AI specialist Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
